Key result
Urokinase-type plasminogen activator regulates arterial remodeling, angiogenesis, and cell proliferation after vascular injury.
Answers are grounded in this paper and cite their sources.
A wide variety of disorders are associated with an imbalance in the plasminogen activator system, including inflammatory diseases, atherosclerosis, intimal hyperplasia, the response mechanism to vascular injury, and restenosis. Urokinase-type plasminogen activator (uPA) is a multifunctional protein that in addition to its fibrinolytic and matrix degradation capabilities also affects growth factor bioavailability, cytokine modulation, receptor shedding, cell migration and proliferation, phenotypic modulation, protein expression, and cascade activation of proteases, inhibitors, receptors, and modulators. uPA is the crucial protein for neointimal growth and vascular remodeling. Moreover, it was recently shown to be implicated in the stimulation of angiogenesis, which makes it a promising multipurpose therapeutic target. This review is focused on the mechanisms by which uPA can regulate arterial remodeling, angiogenesis, and cell migration and proliferation after arterial injury and the means by which it modulates gene expression in vascular cells. The role of domain specificity of urokinase in these processes is also discussed.
No takes yet. Share an insight, caveat, or question.
Va et al. (2009) conducted a review in Disorders of the plasminogen activator system. Urokinase-type plasminogen activator (uPA) was evaluated. Urokinase-type plasminogen activator is a multifunctional protein that regulates arterial remodeling, angiogenesis, cell migration, and proliferation after arterial injury.
Synapse has enriched 10 related papers. Consider them for comparative context: